Madrigal Pharmaceuticals Inc (MDGL)
329.24
+12.15
(+3.83%)
USD |
NASDAQ |
Nov 21, 16:00
329.00
-0.24
(-0.07%)
After-Hours: 20:00
Madrigal Pharmaceuticals Max Drawdown (5Y): 82.20% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 82.20% |
September 30, 2024 | 82.20% |
August 31, 2024 | 82.20% |
July 31, 2024 | 82.20% |
June 30, 2024 | 82.20% |
May 31, 2024 | 82.20% |
April 30, 2024 | 82.20% |
March 31, 2024 | 82.20% |
February 29, 2024 | 82.20% |
January 31, 2024 | 82.20% |
December 31, 2023 | 82.20% |
November 30, 2023 | 82.20% |
October 31, 2023 | 82.20% |
September 30, 2023 | 82.20% |
August 31, 2023 | 82.20% |
July 31, 2023 | 82.20% |
June 30, 2023 | 82.20% |
May 31, 2023 | 82.20% |
April 30, 2023 | 82.20% |
March 31, 2023 | 82.20% |
February 28, 2023 | 82.20% |
January 31, 2023 | 82.20% |
December 31, 2022 | 82.20% |
November 30, 2022 | 88.70% |
October 31, 2022 | 90.40% |
Date | Value |
---|---|
September 30, 2022 | 90.40% |
August 31, 2022 | 95.82% |
July 31, 2022 | 96.22% |
June 30, 2022 | 96.30% |
May 31, 2022 | 96.80% |
April 30, 2022 | 96.80% |
March 31, 2022 | 96.80% |
February 28, 2022 | 96.80% |
January 31, 2022 | 96.80% |
December 31, 2021 | 96.80% |
November 30, 2021 | 96.80% |
October 31, 2021 | 96.80% |
September 30, 2021 | 96.87% |
August 31, 2021 | 97.60% |
July 31, 2021 | 98.32% |
June 30, 2021 | 98.32% |
May 31, 2021 | 98.32% |
April 30, 2021 | 98.32% |
March 31, 2021 | 98.32% |
February 28, 2021 | 98.32% |
January 31, 2021 | 98.40% |
December 31, 2020 | 98.40% |
November 30, 2020 | 98.40% |
October 31, 2020 | 98.40% |
September 30, 2020 | 98.40% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
82.20%
Minimum
Dec 2022
98.40%
Maximum
Nov 2019
91.39%
Average
96.80%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
Corcept Therapeutics Inc | 60.35% |
ADMA Biologics Inc | 84.77% |
89bio Inc | -- |
Sarepta Therapeutics Inc | 64.93% |
Matinas BioPharma Holdings Inc | 99.46% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 26.50 |
Beta (5Y) | -0.4604 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 157.8% |
Historical Sharpe Ratio (5Y) | 0.1302 |
Historical Sortino (5Y) | 0.7861 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.55% |